Newfound Research’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-31
Closed -$3K 229
2018
Q3
$3K Buy
31
+1
+3% +$85 ﹤0.01% 98
2018
Q2
$2K Buy
30
+2
+7% +$150 ﹤0.01% 107
2018
Q1
$2K Hold
28
﹤0.01% 106
2017
Q4
$2K Buy
28
+2
+8% +$128 ﹤0.01% 119
2017
Q3
$2K Buy
26
+3
+13% +$186 ﹤0.01% 114
2017
Q2
$1K Buy
23
+1
+5% +$63 ﹤0.01% 165
2017
Q1
$1K Buy
22
+1
+5% +$69 ﹤0.01% 159
2016
Q4
$1K Hold
21
﹤0.01% 131
2016
Q3
$1K Buy
21
+1
+5% +$75 ﹤0.01% 140
2016
Q2
$2K Buy
+20
New +$1.47K ﹤0.01% 96

Other funds holding ESRX

Newfound Research's ESRX Position: Q4 2018 in Review

Newfound Research sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 31 shares — an estimated $3K sold.

Newfound Research first reported a position in ESRX in Q2 2016 and held it in 10 quarters. The position peaked at $3K in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Newfound Research reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Newfound Research sold 31 Express Scripts Holding Company shares in Q4 2018, an estimated $3K.
  • Newfound Research first reported a position in Express Scripts Holding Company in Q2 2016 and held it in 10 quarters.
  • Newfound Research's Express Scripts Holding Company position peaked at $3K in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Newfound Research's 13F filing for Q4 2018, filed 25 Jan 2019.